Cotara, a monoclonal antibody that targets the DNA of cancer cells and carries a radioactive isotope, is delivered through a method called convection enhanced delivery (CED), which uses a catheter to bypass the blood-brain barrier and target the specific tumor site in the brain.

Image Courtesy: Peregrine Pharmaceuticals, Inc.